Literature DB >> 6493228

Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.

M Goyette, C J Petropoulos, P R Shank, N Fausto.   

Abstract

We examined the transcription of six cellular oncogenes during the process of compensatory growth in rat liver after partial hepatectomy. We have previously reported that transcripts of c-rasH are elevated during regenerative growth of the liver. We now report that transcripts of c-rasK and c-myc genes are significantly elevated after partial hepatectomy, whereas transcripts of c-abl and c-src are essentially unchanged and transcripts of c-mos are undetectable in either normal or regenerating rat liver. In liver regeneration after partial hepatectomy or chemical injury, changes in c-myc transcripts occur before DNA synthesis. The elevation of c-myc and c-ras transcripts is sequential in that highest levels of c-myc transcripts were detected 12 to 18 h after partial hepatectomy, whereas the levels of c-rasH and c-rasK were maximal by 36 to 48 h. Transcripts of all three activated oncogenes returned to their basal levels by 96 h.

Entities:  

Mesh:

Year:  1984        PMID: 6493228      PMCID: PMC368939          DOI: 10.1128/mcb.4.8.1493-1498.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Changes in nuclear and polysomal polyadenylated RNA sequences during rat-liver regeneration.

Authors:  P R Wilkes; G D Birnie; J Paul
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Distribution and specificity of sequences in polyadenylated nuclear RNA of normal, regenerating, and neoplastic liver.

Authors:  N Fausto; G Schultz-Ellison; V Atryzek; M Goyette
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

5.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

6.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.

Authors:  J Campisi; H E Gray; A B Pardee; M Dean; G E Sonenshein
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

8.  Physiological control of repressible acid phosphatase gene transcripts in Saccharomyces cerevisiae.

Authors:  K A Bostian; J M Lemire; H O Halvorson
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

9.  Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.

Authors:  J F Mushinski; S R Bauer; M Potter; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types.

Authors:  R T Maguire; T S Robins; S S Thorgeirsson; C A Heilman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more
  50 in total

1.  Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes.

Authors:  L Kaczmarek; B Calabretta; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

2.  Ovarian expression of cellular Ki-ras p21 varies with physiological status.

Authors:  S Palejwala; L T Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes.

Authors:  K L Mohn; T M Laz; J C Hsu; A E Melby; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

4.  Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice.

Authors:  A J Ouellette; R A Malt; V P Sukhatme; J V Bonventre
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 5.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

Authors:  A Viel; R Maestro; G Toffoli; G Grion; M Boiocchi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 7.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

8.  Adenovirus type 2 activates cell cycle-dependent genes that are a subset of those activated by serum.

Authors:  H T Liu; R Baserga; W E Mercer
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

9.  Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor.

Authors:  Y Yamada; N Fausto
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest.

Authors:  M Dean; R A Levine; J Campisi
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.